Skip to main content

Essential role for migration inhibitory factor in IL-1 activation of mitogen-activated protein kinases

Macrophage migration inhibitory factor (MIF) is a pluripotential proinflammatory cytokine with a possible role in the pathogenesis of rheumatoid arthritis (RA). MIF is expressed in RA synovium, and directly activates RA synoviocyte gene expression and proliferation, as well as exerting anti-apoptotic effects via inhibition of p53. MIF activates ERK and p38 mitogen-activated protein (MAP) kinase, but evidence for direct activation of NF-κB by MIF is lacking.

Anti-MIF monoclonal antibodies prevent IL-1 activation of fibroblast-like synoviocytes in vitro, implicating MIF in the activation of cells by IL-1. The mechanism of this action of MIF has not been adduced. We studied the activation of signal transduction pathways by IL-1 in cells deficient in MIF. Dermal fibroblasts were cultured from MIF-/- and WT mice, and were exposed to IL-1. MAP kinase and NF-κB activation were studied by Western blotting, electrophoretic mobility shift assay (EMSA), and reporter gene assays.

IL-1 rapidly induced phosphorylation of p38, JNK, and ERK MAP kinases in WT cells. In contrast, MIF-/- cell p38, JNK, and ERK activation in response to IL-1 was reduced. Consistent with this observation, MIF-/-cells were hyporesponsive to IL-1-induced AP-1 DNA binding as measured by EMSA (P = 0.03). IL-1-induced activation of an AP-1 luciferase reporter gene system was also reduced in MIF-/- cells (P = 0.037). Confirming the functional significance of these results, MIF-/-cells were hyporesponsive to IL-1-induced proliferation. In contrast, MIF-/- cells were normally responsive to IL-1-induced MKK3 and MKK7 phosphorylation. No significant difference in NF-κB activation was detected between MIF-/- and WT cells, as measured by cellular IκB content, NF-κB EMSA, or NF-κB luciferase reporter gene assay.

These data demonstrate that MIF is required for cellular MAP kinase responses to IL-1. This represents a novel mechanism of action of MIF in the support of the inflammatory response. The absence of an effect on MKK3/MKK7 or NF-κB suggests the effects may be mediated distally in the signal transduction cascade. Therapeutic MIF antagonism may limit the cellular effects of IL-1.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Morand, E., Lacey, D., Yang, Y. et al. Essential role for migration inhibitory factor in IL-1 activation of mitogen-activated protein kinases. Arthritis Res Ther 5, 127 (2003). https://doi.org/10.1186/ar928

Download citation

Keywords

  • Migration Inhibitory Factor
  • Electrophoretic Mobility Shift Assay
  • Luciferase Reporter Gene
  • Reporter Gene Assay
  • Rheumatoid Arthritis Synovium